Patents by Inventor Jinxia LIN

Jinxia LIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystal form of pyrrolidinyl urea derivative and application thereof
    Patent number: 11708357
    Abstract: Disclosed in the present invention are a crystal form of a TrkA inhibitor and a preparation method thereof, and an application thereof in preparation of drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: July 25, 2023
    Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
    Inventors: Fei Hong, Zhiliang Chen, Liju Wang, Jinxia Lin, Wenliang Lan, Yang Zhang, Wentao Wu, Zhixiang Li, Jian Qin
  • CRYSTAL FORM OF PYRROLIDINYL UREA DERIVATIVE AND APPLICATION THEREOF
    Publication number: 20230103409
    Abstract: Disclosed in the present invention are a crystal form of a TrkA inhibitor and a preparation method therefor, and an application thereof in preparation of drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.
    Type: Application
    Filed: January 8, 2021
    Publication date: April 6, 2023
    Applicants: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD., ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
    Inventors: Fei HONG, Zhiliang CHEN, Liju WANG, Jinxia LIN, Wenliang LAN, Yang ZHANG, Wentao WU, Zhixiang LI, Jian QIN
  • Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor
    Patent number: 11597722
    Abstract: The present invention disclosed a crystal form of pyrazine-2(1H)-ketone compound and a preparation method therefor. Specifically disclosed is a method for preparing a compound of formula (II) and a crystal form thereof.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: March 7, 2023
    Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
    Inventors: Zhiliang Chen, Zhiyi Luo, Yichao Zhuang, Jinxia Lin, Longhui Gao, Zhifei Fu, Miaorong Luo, Yang Zhang, Jian Li, Shuhui Chen
  • Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof
    Patent number: 11578081
    Abstract: Disclosed are a crystal form (I) as an inhibitor of ACC1 and ACC2, a preparation method therefor, and the use thereof in the preparation of a drug as an inhibitor of ACC1 and ACC2.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: February 14, 2023
    Assignees: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD., MEDSHINE DISCOVERY INC.
    Inventors: Fei Hong, Jinming Huang, Jinxia Lin, Yichao Zhuang, Zhiyi Luo, Xiaoping Zheng, Zhigan Jiang, Haiying He
  • CRYSTAL FORM AS INHIBITOR OF ACC1 AND ACC2, AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20230034132
    Abstract: Disclosed are a crystal form (I) as an inhibitor of ACC1 and ACC2, a preparation method therefor, and the use thereof in the preparation of a drug as an inhibitor of ACC1 and ACC2.
    Type: Application
    Filed: December 4, 2020
    Publication date: February 2, 2023
    Applicants: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD., MEDSHINE DISCOVERY INC.
    Inventors: Fei HONG, Jinming HUANG, Jinxia LIN, Yichao ZHUANG, Zhiyi LUO, Xiaoping ZHENG, Zhigan JIANG, Haiying HE
  • Pyrazine-2(1H)-ketone compound preparation method
    Patent number: 11535609
    Abstract: Provided are preparation methods for the chemical compound represented by formula (I) and an intermediate thereof.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: December 27, 2022
    Assignee: ZHANGZHOU PIEN TZE HUANG PHARMACEUTICAL CO., LTD.
    Inventors: Jinming Huang, Juan Yu, Jinxia Lin, Limei Yang, Jinxiang Zeng, Zhifei Fu, Miaorong Luo, Yang Zhang, Jian Li, Shuhui Chen
  • PYRAZINE-2(1H)-KETONE COMPOUND PREPARATION METHOD
    Publication number: 20220380350
    Abstract: Provided are preparation methods for the chemical compound represented by formula (I) and an intermediate thereof.
    Type: Application
    Filed: August 4, 2020
    Publication date: December 1, 2022
    Inventors: Jinming HUANG, Juan YU, Jinxia LIN, Limei YANG, Jinxiang ZENG, Zhifei FU, Miaorong LUO, Yang ZHANG, Jian LI, Shuhui CHEN
  • CRYSTAL FORM D OF PYRAZINE-2(1H)-KETONE COMPOUND AND PREPARATION METHOD THEREFOR
    Publication number: 20220281853
    Abstract: Disclosed are a crystal form of pyrazine-2(1H)-ketone compound and a preparation method therefor. Specifically disclosed is a method for preparing a compound of formula (II) and a crystal form thereof.
    Type: Application
    Filed: August 4, 2020
    Publication date: September 8, 2022
    Inventors: Zhiliang CHEN, Zhiyi LUO, Yichao ZHUANG, Jinxia LIN, Longhui GAO, Zhifei FU, Miaorong LUO, Yang ZHANG, Jian LI, Shuhui CHEN
  • 3-ARYLOXY-3-ARYL-PROPYLAMINE COMPOUND AND USES THEREOF
    Publication number: 20220119375
    Abstract: A 3-aryloxy-3-aryl-propylamine compound or a pharmaceutically acceptable salt of same, or a prodrug of same, and uses thereof. The compound has the structure of formula I. The compound, the pharmaceutically acceptable salt of same, or the prodrug of same provides an inhibitory effect with respect to a transient receptor potential (TRP) channel protein, and provides great therapeutic effects with respect to diseases related to the transient receptor potential channel protein.
    Type: Application
    Filed: August 16, 2019
    Publication date: April 21, 2022
    Inventors: Youxin WANG, Jinxia LIN, Zhiliang CHEN, Wenliang LAN, Lingling ZHANG, Zhenlin QU